Hevolution Foundation Launches Grants Program to Encourage Research into the Science of Aging in Saudi Arabia

Pilot Program Will Issue Grants of up to 500,000 Saudi Riyals to Local Researchers RIYADH, Saudi Arabia–(BUSINESS WIRE)–#agingresearch—Hevolution Foundation, a non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, announces a new grants program to encourage research into the aging process in Saudi Arabia, as part of the … [Read more…]

AM-Pharma Provides Business Update and Outcome of Pre-planned Interim Futility Analysis of Phase 3 REVIVAL Study

Phase 3 REVIVAL study stopped per recommendation of data monitoring committee after per-protocol pre-specified interim futility analysis on the study’s primary endpoint, 28-day mortality, without any safety concern. A significant reduction in Major Adverse Kidney Events by day 90 and no difference in overall mortality was observed after review of the data for all 649 … [Read more…]

Patient Centric Healthcare App Global Market Report 2022: Enhanced Access and Flexibility with Novel Technologies Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Patient Centric Healthcare App Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global patient centric healthcare app market is expected to grow at a CAGR of around 21.9% during 2022-2028. This report on global patient centric healthcare app market report provides holistic understanding of … [Read more…]

University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs

TÜBINGEN, Germany & INGELHEIM, Germany–(BUSINESS WIRE)–University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world. Three to five fellowships will be awarded per year for up to three years with a … [Read more…]

Population Services International (PSI) Partners With Babylon to Launch New Digital Service for Low-income Populations in Vietnam

AUSTIN, Texas & WASHINGTON & LONDON–(BUSINESS WIRE)–Population Services International (PSI) announced the launch of a new digital health service in Vietnam to help people in low-income communities make informed decisions about their health and efficiently navigate the healthcare system. Through a partnership with Babylon (NYSE: BBLN), communities in the Bac Ninh province and the Hanoi … [Read more…]

Curaleaf International to Present Positive Clinical and Pre-Clincial Research

Clinical study demonstrates significant improvement in pain LONDON–(BUSINESS WIRE)–Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce that Chief Scientific Officer, Dr Barbara Pacchetti will present research on one clinical study and three preclinical studies at a leading conference on medical cannabis on 21-22 October … [Read more…]

MediCane Health Inc. Announce First Patient Enrolled in a Phase IIa Clinical Trial of MediCane’s Balanced T3:C3 Oral Medical Cannabis Oil for Symptom Relief of Behavioral and Psychological Symptoms of Dementia (BPSD)

KFAR SAVA, Israel–(BUSINESS WIRE)–MediCane Health Inc. (along with its subsidiaries together referred to as “MediCane”) today announced the recruitment of the first patient for its clinical study designed to achieve relief of agitation and disruptive behaviors in subjects with probable Alzheimer’s disease (AD) who do not respond or only partially respond to treatment with antipsychotic … [Read more…]

Approval of extension of exemptions from SIX disclosure and publicity obligations

ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an extension of the various exemptions from certain disclosure and publicity obligations granted by SER to Vifor Pharma AG previously (see Vifor … [Read more…]

Innate Pharma 2023 Financial Calendar

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2023 financial calendar: March 23, 2023: Publication of 2022 financial statements May 10, 2023: Publication of revenue for 1Q2023 May 12, 2023: Annual General Shareholders Meeting September 14, 2023: Publication of half year financial statements November … [Read more…]

Prime Medicine Announces Pricing of Upsized Initial Public Offering

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of its upsized initial public offering of 10,294,118 shares of its common stock at a price to the public of $17.00 per share. All of the shares are being … [Read more…]